Why the study?
To evaluate the accuracy of the ANDON KD-7920 oscillometric wrist blood pressure monitor in the general population according to the ISO 81060-2:2018+AMD1:2020 protocol.
Does the ANDON KD-7920 wrist blood pressure monitor accurately measure blood pressure compared to reference standards in the general population?
Does the ANDON KD-7920 wrist blood pressure monitor accurately measure blood pressure compared to reference standards in the general population?
The ANDON KD-7920 wrist blood pressure monitor meets ISO validation criteria and is accurate for clinical and self-measurement use.
Answers are grounded in this paper and cite their sources.
ISO validation of the ANDON KD-7920 offers initial accuracy data; leaves open routine clinical adoption pending independent confirmation.
OBJECTIVE: This study aimed to evaluate the accuracy of the ANDON KD-7920 oscillometric wrist blood pressure monitor in general population according to the ISO 81060-2:2018+AMD1:2020. METHODS: The same arm sequential method was used for blood pressure measurement among qualified participants according to the ISO 81060-2:2018+AMD1:2020. The validation results were assessed following the criteria of the protocol, and the Bland-Altman scatter plot was used to present the difference between the test device and reference results. RESULTS: A total of 90 participants were included in the study. According to criterion 1 of the validation protocol, the mean ± SD of the differences between the test device and reference readings was 0.76 ± 6.23 mmHg and -0.13 ± 5.57 mmHg for systolic and diastolic blood pressure, respectively, which met the requirements of less than 5 ± 8 mmHg. According to the criterion 2, the average differences between the test device and reference readings per participant were 0.76 ± 5.56 mmHg and -0.13 ± 5.27 mmHg for systolic and diastolic blood pressure, respectively, which also met the requirements. CONCLUSION: The ANDON KD-7920 wrist blood pressure monitor passed all the requirements of the ISO 81060-2:2018+AMD1:2020 and can be recommended for clinical use and self-measurement in general population.
No takes yet. Share an insight, caveat, or question.
Li et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: